UK's Boeringher Ingelheim, the ethical pharmaceutical manufacturer, has reinstated Schroder Investment Management to handle its £80m defined benefit scheme.
SIM fought off stiff competition from four other candidates. A review was initiated last June following concerns over manager performance and also because the scheme had been closed since the end ...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
